S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Total Liabilities & Equity Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Total Liabilities & Equity
NT$6.8B
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
8%
Y
YungShin Global Holding Corp
TWSE:3705
Total Liabilities & Equity
NT$13.4B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
5%
Formosa Laboratories Inc
TWSE:4746
Total Liabilities & Equity
NT$13.4B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
10%
ScinoPharm Taiwan Ltd
TWSE:1789
Total Liabilities & Equity
NT$12B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Total Liabilities & Equity
NT$34.3B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
23%
Standard Chem & Pharm Co Ltd
TWSE:1720
Total Liabilities & Equity
NT$11.8B
CAGR 3-Years
17%
CAGR 5-Years
12%
CAGR 10-Years
8%

See Also

What is SCI Pharmtech Inc's Total Liabilities & Equity?
Total Liabilities & Equity
6.8B TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Total Liabilities & Equity amounts to 6.8B TWD.

What is SCI Pharmtech Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
8%

Over the last year, the Total Liabilities & Equity growth was 26%. The average annual Total Liabilities & Equity growth rates for SCI Pharmtech Inc have been 17% over the past three years , 11% over the past five years , and 8% over the past ten years .

Back to Top